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pregnancy improves the cardiovascular health of
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Daniella E. Duque-Guimarães 1, Laura C. Kusinski 1, Lucas C. Pantaleão 1, Adele G. Pinnock 1,
Catherine E. Aiken 1,2, Dino A. Giussani 3, Denise S. Fernandez-Twinn 1, Susan E. Ozanne 1ABSTRACT
Objective: Obesity during pregnancy is associated with an elevated risk of cardiovascular disease in the offspring. With increased numbers of
women entering pregnancy overweight or obese, there is a requirement for targeted interventions to reduce disease risk in future generations.
Using an established murine model of maternal obesity during pregnancy, we investigated if a treadmill exercise intervention in the mother could
improve offspring cardiac health and explored potential underlying mechanisms.
Methods: A 20-minute treadmill exercise intervention protocol was performed 5 days a week in diet-induced obese female C57BL/6 mice 1
week prior to, and up to E17 of pregnancy. All male offspring were weaned onto a control diet and studied at 8 weeks of age when their
cardiovascular physiology was assessed by in vivo echocardiography and non-invasive tail cuff plethysmography. Cardiomyocyte cell area, re-
expression of fetal genes and the expression of calcium handling and sympathetic activation proteins were determined.
Results: At 8 weeks, there was no difference in bodyweight or fat mass between groups. Offspring of obese dams developed pathologic cardiac
hypertrophy, hypertension and cardiac dysfunction characterized by reduced ejection fraction (p < 0.001). Maternal exercise prevented cardiac
hypertrophy and dysfunction but failed to prevent hypertension. These offspring of exercised dams also had enhanced (p < 0.001) levels of
calcium handling proteins and a sympathetic-activated inotropic response.
Conclusions: Exercise in obese pregnancy was beneficial to offspring cardiac function and structure but did not influence hypertension sug-
gesting they are programmed by separate mechanistic pathways. These data suggest combination interventions in obese pregnancies will be
required to improve all aspects of the cardiovascular health of the next generation.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Cardiovascular disease (CVD) is the number one cause of death
globally [1]. There is already considerable understanding in the car-
diovascular research field that risk factors for disease development are
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on attenuating disease risk by reducing an individual’s modifiable risk
factors postnatally. However there is considerable evidence from hu-
man and animal studies that an adverse environment in utero in-
creases the risk of cardio-metabolic disease in adult life independent
of genetics or their postnatal adult environment [2e4]. Therefore,Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke’s Treatment
K 2Department of Obstetrics and Gynaecology, University of Cambridge, The Rosie
mbridge, CB2 0SW, UK 3Department of Physiology, Development and Neuroscience,
sarah20@gmail.com (S.K. Carr), ld454@medschl.cam.ac.uk (L. Dearden), dd414@
sinski), lp435@medschl.cam.ac.uk (L.C. Pantaleão), apinnock201@gmail.com
ani), df220@cam.ac.uk (D.S. Fernandez-Twinn), seo10@cam.ac.uk (S.E. Ozanne).
e; IVS, Interventricular Septum; LV, Left Ventricle; LVPW, Left Ventricular Posterior
 Available online 18 June 2018
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 35
Original Articlethere is strong rationale that disease risk could be reduced prior to
birth through targeted interventions to the mother before and during
pregnancy [5].
The number of women entering pregnancy either overweight or obese
has risen significantly over the last decade, and in 2014 these
accounted for 50% of pregnancies in the US [6]. These statistics
demonstrate the scale of the problem and highlight the importance of
intervention strategies not only for the immediate [7] but also the long-
term health of both the mother and her child. Studies in humans have
consistently shown that long-term cardiovascular health is compro-
mised in offspring exposed to an obese pregnancy [8e12]. Due to
rising levels of obesity worldwide, it is critical to investigate a targeted
intervention achievable during an obese pregnancy to prevent trans-
mission of poor cardiometabolic health from mother to child. Without
such intervention, the burden of CVD in future generations is likely to
soar. Current guidelines for exercise in pregnant women from the
American Congress of Obstetricians and Gynecologists advise women
with uncomplicated pregnancies to participate in at least 20e30 min of
moderate aerobic and strength conditioning physical activity on most
days of the week [13]. However, most women do not achieve these
recommendations [14]. A number of human trials worldwide have
attempted to alter lifestyle through increased physical activity and/or
dietary modification [15e18]. Although changing behavior is a chal-
lenge, a recent systematic review demonstrated that lifestyle (diet and
physical activity) intervention strategies in pregnancy were enough to
limit gestational weight gain irrespective of the mother’s BMI, ethnicity
and age [19]. Most human pregnancy intervention studies report only
immediate effects during pregnancy and at the point of delivery. Recent
findings from UPBEAT have shown that increased physical activity and a
reduction in glycemic load during pregnancy, reduced offspring
adiposity at 6 months of age [20]. However, due to the long-term nature
of CVD and relative infancy of such intervention studies, data on such
outcomes in humans will not be known for many years. There is,
therefore, a need to model intervention strategies in animals to longi-
tudinally determine the cardiometabolic effects on the offspring.
Our laboratory uses a well-established murine model of maternal diet-
induced obesity in which we mimic human obesity by feeding murine
dams a Western-style diet that is high in sugar and fat. Offspring
develop pathologic cardiac hypertrophy [21] and importantly, the
hearts of these offspring demonstrate impaired function in vivo and
ex vivo, with evidence of sympathetic dominance [22,23] as well as
hypertension [24]. The aim of the current study was to use this model
to test the effectiveness of exercise intervention during obese preg-
nancy at preventing programmed cardiovascular dysfunction in the
adult offspring and to identify underlying molecular mechanisms.
2. METHODS
2.1. Animals
Studies were conducted according to the UK Home Office Animals
(Scientific Procedures) Act 1986 and following ethical review and
approval by the University of Cambridge Animal Welfare and Ethical
Review Board. This study capitalized on an already established
maternal diet-induced obesity model using C57BL/6J mice [25]. At 3
weeks of age, female mice were randomly assigned to receive either a
standard laboratory RM1 diet (approx. 7% simple sugars, 3% fat, 50%
polysaccharide, 15% protein [w/w], 10.74 kJ/g)] or a semi-synthetic,
energy-rich, highly palatable obesogenic diet (approx. 10% simple
sugars, 20% animal lard, 28% polysaccharide, 23% protein [w/w],
28.43 kJ/g) supplemented with sweetened condensed milk (Nestle,
UK) (approx. 16% fat, 33% simple sugars, 15% protein, 13.7 kJ/g),36
 2018 The Authors. Published by Elsevier Gwhich was fortified with mineral and vitamin mix AIN93G. Both diets
were purchased from Special Dietary Services (UK). Detailed energy
content is supplied in Supplementary Table 1. A first pregnancy is
undertaken to prove fertility and establish good maternal care. The
interval between the weaning of the first pregnancy and mating for the
second pregnancy was at least one week and animals were main-
tained on the same diet throughout both pregnancies. From this point,
body composition was assessed using Time Domain-Nuclear Magnetic
Resonance (TD-NMR); this method was chosen to allow longitudinal
non-invasive measurement of body composition in the dams both
before and during pregnancy in the same animal. Once females on the
obesogenic diet reached an absolute fat mass greater than 10 g, they
were considered obese and were mated for the second pregnancy.
Control females were only entered into the study if they had an ab-
solute fat mass under 5 g. These 2 groups of females were rested for
one week before mating (to match for the training week undertaken by
the obese-exercised group), and weekly TD-NMR measurements were
taken before mating and throughout pregnancy. Females were mated
with previously LAD1 fed males (diets were matched to the incoming
female during the period of mating) and maintained on their respective
diets throughout pregnancy and lactation. At the time females were
mated for their second pregnancy, they had been on the diet for
approximately 15 weeks and were approximately 18 weeks old.
2.2. Maternal exercise intervention
For the third group, obese females (>¼ 10 g fat mass) were trained to
run on a treadmill. Treadmill speed was gradually increased over 5
days of training. By day 5, mice were running 20 min per day at a top
speed of 12.5 m/min. Mice were time mated after 1 week of training. A
5-day exercise protocol (weekdays) followed by 2 days rest (weekend)
was continued up to and including gestational day 17. These mice are
referred to as Obese-Exercise (Ob-Ex). The experimental protocol is
shown schematically as part of the graphical abstract.
Litter size (all groups) was standardized to 6 pups on postnatal day 2,
and only male offspring were studied to avoid the influence of sex. At
weaning, all offspring were weaned onto RM1. The N for all experi-
ments corresponds to the number of independent litters (number of
dams, Control n ¼ 16, Obese n ¼ 16 and Ob-Ex n ¼ 7). To eliminate
confounding within litter effects, only one male per litter was used for
each outcome measure. TD-NMR measurements were undertaken
weekly in male offspring from 4 to 8 weeks of age. At eight weeks of
age, mice were fasted overnight (16 h). Tail blood glucose was
measured (Alphatrak 2, Zoetis, USA) before the mice were killed by
rising CO2. Immediately postmortem, blood was collected by cardiac
puncture and tissue was isolated. Our study aimed to address if ex-
ercise during an obese pregnancy was effective at reducing the long-
term detrimental cardiovascular effects on the offspring. As we were
not seeking to investigate the impact of exercise during a lean preg-
nancy, we did not include an exercised control group of dams. This was
to ensure that we were in keeping with the ARRIVE guidelines (NC3Rs)
and only utilized animals required to fulfil our specific research aims.
2.3. Serum analysis
Total serum cholesterol, free fatty acids and triglycerides were
measured by the MRC MDU Mouse Biochemistry Laboratory (Adden-
brooke’s Hospital, UK).
2.4. Histology
Hearts were immersion-fixed in 10% neutral buffered formalin, pro-
cessed and sectioned at 10 mm. Using a previously published method
[23], three mid-cardiac sections from each heart were stained; sixMOLECULAR METABOLISM 16 (2018) 35e44
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hearts (from independent litters) were analyzed per experimental
group. Wheat germ agglutinin [TexasRed-X conjugate, (Molecular
Probes, Life Technologies, USA)] was used to stain cardiomyocyte cell
borders. Images were analyzed double-blinded using CellD software
(Olympus, Japan). Only myocytes in cross-section in which cell borders
were clearly visible were measured. Mid-cardiac cardiomyocyte cell
area was calculated by averaging across at least three fields of view
randomly captured across the LV in the mid-cardiac section and three
mid-cardiac sections were analyzed per heart (w7000 cells were
counted/experimental group).
2.5. Quantitative PCR
Snap-frozen hearts were powdered on dry ice. RNA was extracted
using a miRNeasy mini kit (Qiagen, Germany) following the manu-
facturers protocol. The reverse transcriptase reaction was performed
using a high capacity cDNA RT kit (ABI, USA). Real time qPCR was
carried out in a 384 well plate using SYBR green PCR master mix (ABI,
USA) and performed using a 7900HT fast real-time PCR system (ABI).
All data were normalized to the expression of a housekeeping gene,
Gapdh- Glyceraldehyde 3-phosphate dehydrogenase, the expression of
which was not different between groups (Control, 100 3.1%; Obese,
99.1 4.5%; Ob-Ex, 100.4 4.6%). Gene expression was measured
for Nppa- atrial natriuretic peptide; Nppb- brain natriuretic peptide;
Myh7- b-MHC; Myh6- a-MHC. Primer sequences are shown in
Supplementary Table 2.
2.6. Measuring systolic blood pressure
Non-invasive systolic blood pressure measurements were carried out
using restraint tail cuff plethysmography [BP-2000 Series II (Visitech
systems, Canada)]. Mice were trained on two consecutive days prior to
measurement of systolic blood pressure and pulse rate. Over the
training days, the variation between measurements decreased so that
by the 3rd day the co-efficient of variance was less than 10%. All
sessions were performed at the same time each day (1600 h) to
control for the natural circadian variation of blood pressure and by the
same experimenter. Tail cuff was chosen over telemetry for technical
and scientific reasons. Firstly, telemetry is recommended in mice
heavier than 25 g [26,27], whereas our mice only reached this weight
by post mortem, which was 1 week after blood pressure measure-
ments were performed. Secondly, as echocardiography and blood
pressure was performed on the same mouse, we wanted to avoid the
animal having to be anaesthetized on more than one occasion.
2.7. Echocardiography
Left ventricular function was assessed by transthoracic echocardiog-
raphy (FUJIFILM VisualSonics, Canada, Vevo 770 with a RM707B
30 MHz cardiac transducer). Anesthesia was induced via inhalation of
2% isoflurane in O2 and maintained at 1.5% isoflurane throughout.
Mice were placed in a supine position on a heated platform to enable
real time monitoring of ECG, and body temperature was taken via a
rectal probe. Heart rate was constantly monitored and kept >400
beats per minute (bpm) by modulating flow of isoflurane where
necessary. The transducer was carefully positioned to obtain a para-
sternal long-axis view of the left ventricle (LV). In B-mode the probe
was adjusted to optimally align the aortic valve and apex of the heart,
with the papillary muscle in view. M-mode images were captured from
this position. Measurements were performed using Vevo 770 software.
Cardiac functional outcomes were calculated using the LV tracing
function and lumen and wall dimensions were measured using the in-
built measurement platform on M-mode images. Ascending aortic
diameter was measured from captured EKV files and the width fromMOLECULAR METABOLISM 16 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comwall to wall at mid-systole and diastole was measured within 1 mm of
the aortic valve (Supplementary Fig. 1).
2.8. Western blotting
Ventricular tissue was mechanically homogenized (TissueRuptor, Qia-
gen, Manchester, UK) in lysis buffer [50 mmol/L HEPES, pH 8;
150 mmol/L sodium chloride; 1% Triton X100; 1 mmol/L sodium
orthovanadate; 30 mmol/L sodium fluoride; 10 mmol/L sodium pyro-
phosphate; 10 mmol/L EDTA with a protease inhibitor cocktail (set III),
Calbiochem Novabiochem Biosciences, UK]. Homogenates were
centrifuged, the pellet was discarded, and the supernatant placed in a
fresh tube. Total protein concentration in the cleared lysate was
measured using a copper/bicinchoninic assay (SigmaeAldrich, UK).
Homogenates (10 mg of protein/sample) from all 3 groups were sub-
jected to SDS-PAGE and transferred onto a PVDF membrane (Immo-
bilon-P, Millipore, MA, USA). Membranes were blocked with 5%
skimmed milk protein (Marvel, Premier Foods, UK) in 1x Tris-buffered
Saline (TBS)-0.1% Tween 20 after which they were incubated in pri-
mary antibody at 4 C overnight. All primary antibodies were used at
1:1000 dilution and were obtained from Cell Signaling Technology (MA,
USA): Tropomyosin (#3990S rabbit monoclonal), Troponin I (#4002S
rabbit polyclonal), phosphorylated (Ser23/24) Troponin I (p-Troponin I)
(#4004S rabbit polyclonal) and ATP2A2/SERCA2 (#4388S rabbit poly-
clonal). The following day they were washed in 1x TBS - 0.1% Tween
20 before incubation with horseradish peroxidase-conjugated anti-
rabbit secondary antibody (Jackson ImmunoResearch, Stratech, UK).
Antibody binding was detected using Super Signal West Pico Chemi-
luminescent substrate (Thermo Scientific, UK) and chemiluminescent
bands were quantified directly with Bio-Rad ChemiDoc Imager (USA).
2.9. Statistical analysis
Morphometric and physiologic data were analyzed using Prism7
(Graphpad, USA). Values are expressed as mean  SEM. For maternal
data, two-way ANOVA was carried out with repeated measures to
determine the overall effect of maternal group and time, over mating
and gestation. Otherwise, one-way ANOVA was used to compare the
three experimental groups; a Bonferroni post-hoc test was carried out
when the overall P value for ANOVA was less than 0.05.
Cell area data were analyzed using a hierarchical linear model. A hier-
archical linear model with random effects for individual animal, and an
interactive effect between individual and section of origin was used to
analyze cardiomyocyte cell area. The model included maternal diet and
maternal exercise as fixed effects. This structure accounted for the fact
that multiple cell area measurements were obtained from multiple sec-
tions of the heart of each individual animal within the groups, and these
data cannot be treated as fully independent [R statistical software
package version 2.14.1 (R Foundation for Statistical Computing, Austria)].
3. RESULTS
3.1. Maternal body composition
Compared to controls, obese females had increased body weight at the
start of pregnancy that was maintained throughout pregnancy and
lactation (Figure 1A). This increase was a result of increased fat mass
at all time points (Figure 1B). Maternal exercise in the obese dams did
not alter maternal body weight or composition when compared to non-
exercised obese dams (Figure 1).
During the second week of pregnancy, obese dams had decreased
lean mass when compared to control dams. This reduction in lean
mass was not ameliorated by the exercise intervention (Figure 1C). As
TD-NMR measurements cannot distinguish between the bodyopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 37
Figure 1: Maternal body composition. A) Body weight. TD-NMR was used to assess B) Fat mass and C) Lean mass of dams. Week 0 ¼ day females were set up for timed
mating. Data points are separated by 1 week. Control n ¼ 12, Obese n ¼ 12 and Ob-Ex n ¼ 11. **p < 0.01 and ***p < 0.001).
Original Articlecomposition of the dam and her pups, this deficit could be accounted
for by the fact that both Obese and Ob-Ex groups had a reduced litter
size at birth (Control, 8.3  0.4; Obese, 6.3  0.4; Ob-Ex, 6.0  0.5;
p ¼ 0.002) and a decreased total litter weight (Control, 11.1  0.4 g;
Obese, 9.6  0.4 g; Ob-Ex, 8.8  0.5 g; p ¼ 0.003).
3.2. Offspring body composition
There was no difference in body weight or lean mass between the three
offspring groups at 8 weeks of age. However, there was an overall trend
(p ¼ 0.06) for the offspring of obese dams to have increased fat mass
(Table 1). Serological analysis showed no differences between offspring
groups for free fatty acid and triglyceride levels. Total cholesterol was
not significantly altered between offspring of control or obese dams;
however the intervention group had decreased serum cholesterol when
compared to control offspring (Table 2). There were no changes in
fasting plasma glucose between groups. However, it has been previ-
ously reported that hyperinsulinemia in the offspring of obese dams is
corrected by maternal exercise [25].
3.3. Assessing cardiac hypertrophy
Male offspring from obese dams had increased heart weight at 8
weeks of age, both in absolute terms and when expressed relative toTable 1 e Offspring body composition and heart weight.
Control N Ob
Fed BW (g) 25.5  0.3 6 25.6 
Fat mass (g) 2.3  0.1 6 3.1 
Lean mass (g) 18.5  0.3 6 18.1 
Fasted BW (g) 22.8  0.4 11 22.4 
Heart weight (mg) 130.6  3.8 11 156.8
Relative heart weight (%BW) 0.57  0.01 11 0.66 
Body composition was performed by TD-NMR under fed conditions. 16 h fasted body we
calculated by one-way ANOVA and shown in bold when a significant difference was detecte
hoc test (p < 0.05) a Control vs. Obese and c Obese vs. Ob-Ex.
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increased (Figure 2A,B). These parameters were normalized in
offspring from the Ob-Ex group (Table 1 and Figure 2A,B). Frequency
distribution of cardiomyocyte cell areas from all groups showed a
rightward shift, indicative of a higher proportion of larger cells in the
offspring of obese dams, thereby confirming hypertrophy (Figure 2C).
Hierarchical linear model analysis showed that the p value for the
effect of maternal diet to increase cell size was p < 0.001, and for
exercise to prevent this increase was p < 0.001.
Atrial natriuretic peptide (Nppa) expression was increased approxi-
mately three-fold in the obese dam offspring hypertrophic hearts; this
expression was normalized in the Ob-Ex group (Figure 2D). Further-
more the Myh7: Myh6 ratio was increased in the hearts of offspring
exposed to maternal obesity, which was driven by increased Myh7
rather than Myh6 (Figure 2D). This was also normalized in the inter-
vention group (Figure 2D).
3.4. Quantification of systolic blood pressure
Exposure to maternal obesity increased systolic blood pressure.
Maternal exercise was unable to prevent this programmed hyperten-
sion (Figure 3A). There were no accompanying changes in pulse rate
between any of the groups (Figure 3B).ese N Ob-Ex N p value
0.3 6 25.6  0.5 5 0.98
0.3 6 2.6  0.3 5 0.06
0.3 6 18.1  0.3 5 0.56
0.7 9 23.2  0.3 9 0.55
 5.7ac 9 135.9  2.0 9 <0.001
0.02ac 9 0.59  0.01 9 <0.001
ight (BW) was measured to allow normalization of fasted heart weight. P values were
d (p < 0.05). Letters represent differences between specified groups by Bonferroni post-
MOLECULAR METABOLISM 16 (2018) 35e44
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Table 2 e Serological analysis in 8 week offspring.
Analytes (mmol/L) Control N Obese N Ob-Ex N p value
Triglycerides 1.19  0.07 9 1.25  0.09 6 1.48  0.14 9 0.14
Free Fatty Acids 926.9  49.0 9 935.0  105.7 6 799.6  87.8 9 0.79
Total Cholesterol 3.53  0.08 8 3.38  0.06 5 3.18  0.09b 9 0.02
Plasma Glucose 5.4  0.3 9 6.1  0.2 6 6.4  0.4 9 0.20
Analytes were analyzed in overnight fasted (16 h) serum from male offspring at 8 weeks of age. P values were calculated by one-way ANOVA and shown in bold when a significant
difference was detected (p < 0.05). Letters represent differences between specified groups by Bonferroni post-hoc test (p < 0.05) b Control vs. Ob-Ex.The diameter of the ascending aorta at end-systole was increased in
male offspring exposed to maternal obesity and this was not corrected
in the Ob-Ex group (Figure 3C). The difference in aortic diameter be-
tween end-systole and end-diastole was increased in male offspring
exposed to maternal obesity and this was also not corrected by the
maternal exercise intervention (Figure 3D).
3.5. Echocardiography
Left ventricular end-systolic volume (ESV) was elevated in male offspring
from obese dams (Figure 4A). This resulted in an accompanying
reduction in ejection fraction (Figure 4B). This contributed to a significant
overall effect of maternal obesity to reduce cardiac output in the
offspring despite no differences in heart rate (Table 3). Furthermore,Figure 2: Pathologic LV cardiac hypertrophy in male offspring at 8 weeks of age. A)
cardiomyocyte cell area. C) Frequency distribution of cardiomyocyte cell area. N ¼ 6 heart
Housekeeper glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was unchanged betwee
***p < 0.001. Nppa- atrial natriuretic peptide; Nppb- brain natriuretic peptide; Myh7- b-
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offspring of obese mothers suggesting impaired cardiac contractility
(Figure 4C). This was confirmed by a reduction in ventricular fractional
shortening in the offspring of obese dams (Figure 4D).
Offspring from the Ob-Ex group no longer showed an increased left
ventricular ESV and end-systolic diameter, and the ejection fraction
and fractional shortening was restored to values matching control
offspring (Figure 4AeD). Structurally, the diameter of the IVS and
LVPW at systole in the intervention group was increased compared to
the offspring of non-exercised obese dams. This resulted in an
increased systolic wall: lumen width ratio in the offspring of the ex-
ercise group. There were no significant differences in the wall or lumen
measurements between any groups at the end of diastole (Table 3).Representative images of wheat germ agglutinin stained mid-cardiac sections. B) Mean
s per group withw7000 cells analyzed per group. D) Ventricular fetal gene expression.
n groups. Control n ¼ 9, Obese n ¼ 7 and Ob-Ex n ¼ 9. *p < 0.05, **p < 0.01 and
MHC; Myh6- a-MHC.
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 39
Figure 3: Offspring blood pressure and aortic diameter. A) Systolic blood pressure B) Pulse rate (bpm) as measured by tail cuff plethysmography. Control n ¼ 16, Obese
n ¼ 14 and Ob-Ex n ¼ 10. C) Ascending aortic (Asc Ao) diameter measured using EKV images using echocardiography. Control n ¼ 13, Obese n ¼ 10 and Ob-Ex n ¼ 6. D)
Difference in aortic diameter between end-systole and end-diastole. Control n ¼ 10, Obese n ¼ 9 and Ob-Ex n ¼ 4. **p < 0.01 and ***p < 0.001.
Original Article3.6. Assessing cardiac contractile machinery proteins
Although maternal obesity did not have any effect on the levels of any
of the key cardiac contractile machinery proteins (compared to the
control group), levels of Troponin I and Tropomyosin were increased
over two-fold in the heart tissue from the Ob-Ex group compared to
controls (Figure 4E). Levels of activated p-Troponin I (Ser23/24) were
also increased, which reflected an increase in the p-Troponin I: total
Troponin I ratio compared to the other two groups. Furthermore,
SERCA2, a protein involved in the recycling of calcium, was also
increased in the adult male offspring from the Ob-Ex group compared
to the other groups (Figure 4E).
4. DISCUSSION
The current study addressed the effectiveness of a maternal treadmill
exercise intervention during obese pregnancy at preventing pro-
grammed cardiovascular dysfunction in male offspring. We found that
20min of exercise, 5 days a week, 1 week prior to and during pregnancy
prevented programmed development of pathologic cardiac hypertrophy
and cardiac dysfunction at 8 weeks of age without normalizing maternal
body weight. However, despite the clear rescue of the offspring cardiac
phenotype in the current study (and metabolic phenotype in previously
published studies by us [25] and others [28]), maternal exercise inter-
vention did not prevent hypertension. This highlights divergence of
programming pathways that lead to cardiac dysfunction and hyperten-
sion. In addition, at a translational level, this provides important evidence
that it is not always necessary to alter maternal body weight or fat mass
following intervention to improve the offspring phenotype. As many
human intervention studies have not observed changes in gestational
weight gain in the mother, it offers an important message that exercise
without weight loss can still have long-term benefit, and it is therefore
critical to study offspring long-term.40
 2018 The Authors. Published by Elsevier G4.1. Maternal exercise prevented offspring pathologic cardiac
hypertrophy and cardiac dysfunction
During cardiac stress such as hemodynamic overload, there is re-
expression of fetal genes, which can lead to decompensation and
heart failure [29]. Induction of Nppa and Myh7 are highly conserved
features of ventricular pathological hypertrophy [30,31]. Myh6 (a-
MHC, adult isoform) and Myh7 (b-MHC, fetal isoform) are two func-
tionally distinct cardiac isoforms; Myh7 has a lower sliding velocity
therefore an increased ratio of Myh7: Myh6 negatively impacts on
cardiac function [32]. Maternal obesity caused the upregulation of
Nppa and Myh7 in cardiac tissue of adult male offspring, concurrent
with other markers of pathologic cardiac hypertrophy including
increased heart weight and cardiomyocyte cell area.
While the development of pathologic cardiac hypertrophy and cardiac
dysfunction has been well described in the offspring of obese dams
[21,22], the effects of maternal exercise in obese pregnancy on the
cardiovascular health of the offspring has yet to be elucidated.
Maternal exercise was beneficial to molecular and histologic markers
of pathologic cardiac hypertrophy as well as restoring offspring cardiac
function to control levels.
4.2. Discordant programming pathways
Consistent with previous studies, offspring of obese dams were hy-
pertensive compared to controls [24,33]. Despite correcting cardiac
dysfunction, maternal exercise intervention failed to prevent offspring
hypertension. These findings highlight discordance between the
mechanisms through which maternal obesity during pregnancy me-
diates the programming effects on offspring cardiac dysfunction,
compared to those leading to hypertension. Our data suggest that
cardiac hypertrophy measured in offspring of obese dams is not a
consequence of hypertension but instead programmed through a
mechanism modifiable through maternal exercise intervention. TheMOLECULAR METABOLISM 16 (2018) 35e44
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Figure 4: Offspring cardiac function by in vivo echocardiography. A)-D) LV systolic function and contractility measured by echocardiography. Control n ¼ 16, Obese n ¼ 16
and Ob-Ex n ¼ 7. E) Assessment of proteins important in contractile machinery, blots shown in Supplementary Fig. 2. Control n ¼ 9, Obese n ¼ 8 and Ob-Ex n ¼ 8. *p < 0.05,
**p < 0.01 and *** p < 0.001. TnI- total Troponin I, p-TnI- p-Troponin I and Tpm- Tropomyosin.fact that hypertension was not corrected in the offspring exposed to
maternal exercise intervention leads us to assess maternal factors not
corrected by the intervention as a potential mechanism. The exercise
intervention improved maternal insulin sensitivity [25]; therefore,
maternal hyperinsulinemia could play a role in mediating offspring
cardiac dysfunction but clearly improving insulin sensitivity was
insufficient to prevent the increased blood pressure in the offspring.
Therefore, a different programming factor is likely mediating the
adverse effects on offspring blood pressure. One such factor is
maternal leptin, which we [25] and others [28] have shown is not
corrected by maternal exercise intervention. It has been shown that
inducing experimental hyperleptinemia in neonatal rat pups from
postnatal day 9e15 causes increased blood pressure in adulthood
[34] and programs long-term renal structural and functional
damage through renal sympathetic nerve activation [35]. It has also
been suggested that an exaggerated neonatal leptin surge stimu-
lates hypothalamic melanocortin signaling leading to alteredMOLECULAR METABOLISM 16 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comsympathetic tone [24]. The lack of effectiveness at the exercise
intervention to prevent offspring hypertension, therefore, may be
related to the maintained hyperleptinaemia in the exercised obese
dams.
In humans persistent hypertension can cause significant enlargement
of the aortic root width, compared to age and sex-matched populations
of similar body size [36]. We observed a greater increase in aortic
width following ventricular contraction, consistent with our functional
data that show adult offspring from obese dams experience an
increased afterload. The afterload in these offspring was great enough
to adversely impact on left ventricular systolic function and myocardial
contractility, as ESV was increased, and fractional shortening and
ejection fraction were reduced. This suggests that adult offspring of
obese mothers cannot maintain cardiac output, a pre-eminent feature
of heart failure [37]. Failure to maintain adequate cardiac workload has
been shown ex vivo in fetal sheep offspring exposed to maternal
overnutrition [38].open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 41
Table 3 e In vivo echocardiographic parameters.
Control Obese Ob-Ex p value
End diastolic volume (ml) 58.9  3.9 68.4  3.0 59.2  3.0 0.097
End diastolic diameter (mm) 3.70  0.10 3.95  0.08 3.72  0.08 0.092
Stroke volume (ml) 41.39  1.9 38.85  1.3 43.26  1.4 0.250
Heart Rate (bpm) 443  12 421  11 446  17 0.291
Cardiac output (ml/min) 18.2  0.8 16.31  0.6 19.37  1.18 0.046
IVS; diastole (mm) 0.924  0.04 0.869  0.05 0.957  0.05 0.440
LVID; diastole (mm) 3.65  0.10 3.92  0.07 3.71  0.07 0.061
LVPW; diastole (mm) 0.85  0.04 0.82  0.03 0.89  0.07 0.620
Wall: Lumen ratio; diastole 0.24  0.01 0.21  0.01 0.24  0.02 0.279
IVS; systole (mm) 1.37  0.05 1.25  0.05 1.51  0.09c 0.019
LVID; systole (mm) 2.32  0.12 2.82  0.10ac 2.24  0.14 0.003
LVPW; systole (mm) 1.34  0.05 1.18  0.05 1.42  0.11c 0.030
Wall: Lumen ratio; systole 0.57  0.04 0.43  0.03 0.65  0.08c 0.007
LV mass (mg) 90.2  3.6 98.0  3.9 97.6  10.0 0.453
LV ¼ Left ventricle, IVS¼ Interventricular septum, LVID ¼ LV internal diameter and LVPW ¼ LV posterior wall. Control n ¼ 16, Obese n ¼ 16 and Ob-Ex n ¼ 7. P values were
calculated by one-way ANOVA and shown in bold when a significant difference was detected (p < 0.05). Letters represent differences between specified groups by Bonferroni post
hoc test (p < 0.05) a Control vs. Obese, b Control vs. Ob-Ex and c Obese vs. Ob-Ex.
Original Article4.3. Mechanisms underlying improved offspring cardiac
dysfunction following maternal exercise intervention
The offspring from exercised obese dams showed an improvement in
cardiac function despite remaining hypertensive and experiencing
increased afterload. Restored ejection fraction, cardiac output and
fractional shortening suggest these offspring are overcoming their
increase in afterload through compensatory increases in cardiac
contractility. Modulation of calcium pathways is critical for the heart to
adapt to changing workloads [39]. Key proteins in these pathways
were elevated in ventricular tissue from offspring of obese-exercised
mothers compared to offspring of both control and non-exercised
obese mothers, supporting a role for increased inotropy as a poten-
tial driver of their improved cardiac function. Sympathetic activation
occurs through b1-adrenergic receptor, which activates Protein Kinase
A and the phosphorylation of Troponin I; this increases the calcium
sensitivity of Troponin C causing an increased off-rate of calcium,
allowing accelerated cardiac relaxation [40]. An up-regulation of pro-
teins in this pathway is indicative of an enhanced sympathetic
response. Furthermore, elevated SERCA2 expression would allow
calcium to be recycled back to the sarcoplasmic reticulum facilitating
efficient future cardiac contractions. Total Troponin I and Tropomyosin
in the myocardium were also increased and could further explain the
improved cardiac function.
4.4. Conclusions
Whilst not all exercise and lifestyle intervention strategies during preg-
nancy have proved to have immediate benefit to themother and neonate,
our study highlights the importance of exercise in obese pregnancy in
reducing long-term cardiovascular risk to the offspring and, therefore,
the need for follow up studies across the life course. Just a small
improvement in offspring risk could have important implications for the
future burden of CVD worldwide. Mechanistically, our study demon-
strates that offspring cardiac hypertrophy and dysfunction can be pro-
grammed independently of hypertension by adverse intrauterine
conditions. Therefore, there is a potential need for combination inter-
vention strategies to tackle the epidemic of obesity in pregnancy, to help
reduce all aspects of the future burden of CVD onto the next generation.
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